• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

CD30/CD16 Antibody – Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS1580275

MBS1580275 is an antibody targeting CD30/CD16. Also known as Research Grade Anti-Human CD30/CD16 Antibody (AFM13). Reactive in Human. More details

$580 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
CD30/CD16, Monoclonal Antibody
Full Product Name
Research Grade Anti-Human CD30/CD16 Antibody (AFM13)
Product Gene Name
anti-CD30/CD16 antibody
Clonality
Monoclonal
Species Reactivity
Human
Form/Format
Liquid; 0.01M PBS, pH 7.4.
Purity/Purification
>95% by SDS-PAGE.
Protein A or G purified from cell culture supernatant.
Concentration
1mg/ml (lot specific)
Preparation and Storage
Store at +4 degree C short term (1-2 weeks), -20 degree C 12 months, -80 degree C long term. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Molecular Weight
50,935 Da
OMIM
153243
3D Structure
ModBase 3D Structure for P28908
Expression system
Mammalian cells
Target
CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30, CD16a, CD16A, FCGR3A, Fc-gamma RIII-alpha, FcRIIIa, IgG Fc receptor III-2, Low affinity immunoglobulin gamma Fc region receptor III-A, IGFR3, CD16a antigen, Fc-gamma RIII, FCGR3, Fc-gamma RIIIa, FCG3, FcRIII, FcR-10; VH-VL-VH-VL
Host Species
Humanized

Product Categories/Family for anti-CD30/CD16 antibody

Research Biosimilar
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-CD30/CD16 antibody
Research Grade Biosimilar

Other Notes

Small volumes of anti-CD30/CD16 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for CD30/CD16. It may not necessarily be applicable to this product.

NCBI GI #
597709795
NCBI GeneID
943
NCBI Accession #
NP_001234.3
UniProt Primary Accession #
P28908
UniProt Secondary Accession #
P08637
UniProt Related Accession #
P28908
GenBank Nucleotide #
NM_001243.4
NCBI Official Full Name
tumor necrosis factor receptor superfamily member 8 isoform 1
NCBI Official Synonym Full Names
tumor necrosis factor receptor superfamily member 8
NCBI Official Symbol
TNFRSF8
NCBI Official Synonym Symbols
CD30; Ki-1; D1S166E
UniProt Protein Name
Tumor necrosis factor receptor superfamily member 8
UniProt Synonym Protein Names
CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; CD_antigen: CD30
UniProt Gene Name
TNFRSF8
UniProt Synonym Gene Names
CD30; D1S166E
UniProt Entry Name
TNR8_HUMAN
NCBI Protein Information
tumor necrosis factor receptor superfamily member 8

UniProt Comments for CD30/CD16

TNFRSF8: Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF- kappa-B. 2 isoforms of the human protein are produced by alternative initiation.

Protein type: Membrane protein, integral; Receptor, misc.

Chromosomal Location of Human Ortholog: 1p36

Cellular Component: integral to plasma membrane

Molecular Function: transmembrane receptor activity; tumor necrosis factor receptor activity

Biological Process: immune response; inflammatory response; multicellular organismal development; negative regulation of cell proliferation; positive regulation of apoptosis; positive regulation of TRAIL biosynthetic process; positive regulation of tumor necrosis factor biosynthetic process; response to lipopolysaccharide; signal transduction
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with anti-CD30/CD16 antibody

 Reference Product  PubMed Publications
 CD4 antibody  >415 publications with CD30/CD16 and CD4
 ALK antibody  >200 publications with CD30/CD16 and ALK
 CD5 antibody  >105 publications with CD30/CD16 and CD5
 TNFSF8 antibody  >97 publications with CD30/CD16 and TNFSF8
 TRAF2 antibody  >36 publications with CD30/CD16 and TRAF2
 TRAF1 antibody  >27 publications with CD30/CD16 and TRAF1
 ICAM1 antibody  >23 publications with CD30/CD16 and ICAM1
 TRAF3 antibody  >13 publications with CD30/CD16 and TRAF3
 TRAF5 antibody  >10 publications with CD30/CD16 and TRAF5
 FUT4 antibody  >6 publications with CD30/CD16 and FUT4

Pathways associated with anti-CD30/CD16 antibody

 Products by Pathway  Pathway Diagram
 Cytokine-cytokine Receptor Interaction Pathway antibodies  Cytokine-cytokine Receptor Interaction Pathway Diagram
 Cytokine-cytokine Receptor Interaction Pathway antibodies  Cytokine-cytokine Receptor Interaction Pathway Diagram
 TNF-alpha/NF-kB Signaling Pathway antibodies  TNF-alpha/NF-kB Signaling Pathway Diagram

Diseases associated with anti-CD30/CD16 antibody

 Disease Name  Pubmed Publications
 Hodgkin Disease Antibodies  >600 publications with CD30/CD16 and Hodgkin Disease
 Necrosis Antibodies  >318 publications with CD30/CD16 and Necrosis
 Inflammation Antibodies  >96 publications with CD30/CD16 and Inflammation
 Cell Transformation, Neoplastic Antibodies  >66 publications with CD30/CD16 and Cell Transformation, Neoplastic
 Fever Antibodies  >64 publications with CD30/CD16 and Fever
 Hyperplasia Antibodies  >59 publications with CD30/CD16 and Hyperplasia
 Neoplasm Metastasis Antibodies  >51 publications with CD30/CD16 and Neoplasm Metastasis
 Disease Models, Animal Antibodies  >47 publications with CD30/CD16 and Disease Models, Animal
 Liver Diseases Antibodies  >46 publications with CD30/CD16 and Liver Diseases
 Kidney Diseases Antibodies  >29 publications with CD30/CD16 and Kidney Diseases

Organs/Tissues associated with anti-CD30/CD16 antibody

 Organ/Tissue Name  Pubmed Publications
 Blood Antibodies  >1210 publications with CD30/CD16 and Blood
 Lymph Node Antibodies  >360 publications with CD30/CD16 and Lymph Node
 Lung Antibodies  >79 publications with CD30/CD16 and Lung
 Intestine Antibodies  >28 publications with CD30/CD16 and Intestine
 Embryonic Tissue Antibodies  >24 publications with CD30/CD16 and Embryonic Tissue
 Testis Antibodies  >23 publications with CD30/CD16 and Testis
 Uterus Antibodies  >7 publications with CD30/CD16 and Uterus
 Salivary Gland Antibodies  >2 publications with CD30/CD16 and Salivary Gland
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000